COVID-19: consider cytokine storm syndromes and immunosuppression
- 16 March 2020
- journal article
- letter
- Published by Elsevier BV in The Lancet
- Vol. 395 (10229), 1033-1034
- https://doi.org/10.1016/s0140-6736(20)30628-0
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, ChinaIntensive Care Medicine, 2020
- Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injuryThe Lancet, 2020
- Baricitinib as potential treatment for 2019-nCoV acute respiratory diseaseThe Lancet, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Macrophage Activation-Like Syndrome: A Distinct Entity Leading to Early Death in SepsisFrontiers in Immunology, 2019
- Pulmonary Involvement in Patients With Hemophagocytic LymphohistiocytosisSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2016
- Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation SyndromeCritical Care Medicine, 2016
- Development and Validation of the HScore, a Score for the Diagnosis of Reactive Hemophagocytic SyndromeArthritis & Rheumatology, 2014
- Adult haemophagocytic syndromeThe Lancet, 2014